Home » Topics » BioWorld Science

BioWorld Science
RSS

Biomea nominates third-generation FLT3 inhibitor as IND candidate

May 20, 2022

PostEra's AI approach to accelerate NIH-funded work for pandemic preparedness

May 20, 2022

FDA grants orphan drug designation to XMT-2056 for gastric cancer

May 20, 2022

Myrtelle enters licensing agreement with Rescue Hearing for gene therapy for genetic hearing loss

May 20, 2022

ORT-247 demonstrates efficacy in preclinical models of CMT and ALS

May 20, 2022

Clearmind's MEAI shows suppressive effect on alcohol consumption in mice

May 20, 2022

Preclinical studies of JAG-101, a gene therapy for type 1 galactosemia

May 20, 2022

HDAC6 inhibitor CKD-510 shows promise for the treatment of CMT1A

May 20, 2022

Novel mouse models of RP59 retinal degeneration

May 20, 2022

Chulalongkorn University presents compounds for treating hepatitis B virus infections

May 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...